Titre:
  • Safety and pharmacokinetics of sorafenib combined with capecitabine in patients with advanced solid tumors: results of a phase 1 trial.
Auteur:Awada, Ahmad; Gil, Thierry; Whenham, Nicolas; Van Hamme, Julie; Besse-Hammer, Tatiana; Brendel, Erich; Delesen, Heinz; Joosten, Miranda C; Lathia, Chetan; Loembé, Bienvenu A; Piccart-Gebhart, Martine; Hendlisz, Alain
Informations sur la publication:Journal of clinical pharmacology, 51, 12, page (1674-1684)
Statut de publication:Publié, 2011-12
Sujet CREF:Cancérologie
MeSH keywords:Adult
Aged
Antineoplastic Agents -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- blood -- pharmacokinetics
Area Under Curve
Benzenesulfonates -- administration & dosage
Colonic Neoplasms -- drug therapy -- metabolism
Deoxycytidine -- administration & dosage -- analogs & derivatives
Diarrhea -- chemically induced
Fatigue -- chemically induced
Female
Fluorouracil -- administration & dosage -- analogs & derivatives
Hand-Foot Syndrome -- etiology
Humans
Male
Middle Aged
Neoplasms -- drug therapy -- metabolism
Protein Kinase Inhibitors -- administration & dosage
Pyridines -- administration & dosage
Note générale:Clinical Trial, Phase I
Journal Article
Research Support, Non-U.S. Gov't
FLWIN
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0091-2700
info:doi/10.1177/0091270010386226
info:pii/0091270010386226
info:scp/80051564889
info:pmid/21209247